» Articles » PMID: 37907984

The Important Role of MiR-1-3p in Cancers

Overview
Journal J Transl Med
Publisher Biomed Central
Date 2023 Nov 1
PMID 37907984
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a malignant tumor that seriously threatens human life and health. At present, the main treatment methods include surgical resection, chemotherapy, radiotherapy, and immunotherapy. However, the mechanism of tumor occurrence and development is complex, and it produces resistance to some traditional treatment methods, leading to treatment failure and a high mortality rate for patients. Therefore, exploring the molecular mechanisms of tumor occurrence, development, and drug resistance is a very important task. MiRNAs are a type of non-coding small RNA that regulate a series of biological effects by binding to the 3'-UTR of the target mRNA, degrading the mRNA, or inhibiting its translation. MiR-1-3p is an important member of them, which is abnormally expressed in various tumors and closely related to the occurrence and development of tumors. This article introduces miR-1-3p from multiple aspects, including its production and regulation, role in tumor occurrence and development, clinical significance, role in drug resistance, and approaches for targeting miR-1-3p. Intended to provide readers with a comprehensive understanding of the important role of miR-1-3p in tumors.

Citing Articles

Intervening Non-Small-Cell Lung Cancer Progression by Cell Membrane Coated Platycodin D via Regulating Hsa-miR-1246/FUT9/GSK3β Pathway.

Zheng S, Xie Z, Zhou Z, Wang S, Xin Y, Lin J Int J Nanomedicine. 2025; 20:1661-1678.

PMID: 39931532 PMC: 11809235. DOI: 10.2147/IJN.S479675.


Exosomes loaded with the anti-cancer molecule mir-1-3p inhibit intrapulmonary colonization and growth of human esophageal squamous carcinoma cells.

Yu Y, Jin B, Jia R, Shi L, Chen Y, Ge J J Transl Med. 2024; 22(1):1166.

PMID: 39741298 PMC: 11687107. DOI: 10.1186/s12967-024-05997-9.


microRNA-1 Regulates Metabolic Flexibility in Skeletal Muscle via Pyruvate Metabolism.

Ismaeel A, Peck B, Montgomery M, Burke B, Goh J, Kang G bioRxiv. 2024; .

PMID: 39149347 PMC: 11326265. DOI: 10.1101/2024.08.09.607377.


Screening and identification of miRNAs negatively regulating FAM83A/Wnt/β-catenin signaling pathway in non-small cell lung cancer.

Yuan W, Liu W, Huang H, Chen X, Zhang R, Lyu H Sci Rep. 2024; 14(1):17394.

PMID: 39075121 PMC: 11286843. DOI: 10.1038/s41598-024-67686-3.


Unveiling the Mechanisms Underlying the Immunotherapeutic Potential of Gene-miRNA and Drugs in Head and Neck Cancer.

Danishuddin , Haque M, Malik M, Arya R, Singh P, Lee J Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065771 PMC: 11280033. DOI: 10.3390/ph17070921.


References
1.
Guo C, Zhou S, Yi W, Yang P, Li O, Liu J . SOX9/MKLN1-AS Axis Induces Hepatocellular Carcinoma Proliferation and Epithelial-Mesenchymal Transition. Biochem Genet. 2022; 60(6):1914-1933. DOI: 10.1007/s10528-022-10196-6. View

2.
Deng L, Jiang L, Lin X, Tseng K, Liu Y, Zhang X . The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia. Acta Pharmacol Sin. 2017; 38(3):382-391. PMC: 5342661. DOI: 10.1038/aps.2016.121. View

3.
Zhou Y, Liang X, Chang H, Shu F, Wu Y, Zhang T . Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress. Cancer Sci. 2014; 105(10):1279-87. PMC: 4462353. DOI: 10.1111/cas.12494. View

4.
Wang Z, Wang J, Chen Z, Wang K, Shi L . MicroRNA-1-3p inhibits the proliferation and migration of oral squamous cell carcinoma cells by targeting DKK1. Biochem Cell Biol. 2017; 96(3):355-364. DOI: 10.1139/bcb-2017-0015. View

5.
Gao Y, Qian H, Tang X, Du X, Wang G, Zhang H . Superparamagnetic iron oxide nanoparticle-mediated expression of inhibits human endometrial carcinoma stem cell growth. Int J Nanomedicine. 2019; 14:2719-2731. PMC: 6497851. DOI: 10.2147/IJN.S200480. View